Stefan Michiels

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

Sherene Loi, Nicolas Sirtaine, Fanny Piette et al. · Journal of Clinical Oncology · 2013 · 1.6K citations

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

Sherene Loi, Stefan Michiels, Roberto Salgado et al. · Annals of Oncology · 2014 · 1.3K citations

Breast Oncology, Cancer Immunosurveillance, Medicine +10

CD4+ follicular helper T cell infiltration predicts breast cancer survival

Chunyan Gu‐Trantien, Sherene Loi, Soizic Garaud et al. · Journal of Clinical Investigation · 2013 · 1K citations

Lymphocyte Development, T-regulatory Cell, Immunology +20

Prediction of cancer outcome with microarrays: a multiple random validation strategy

Stefan Michiels, Serge Koscielny, Catherine Hill · The Lancet · 2005 · 988 citations

Oncology, Cancer Outcome, Medicine +9

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

Sherene Loi, Damien Drubay, Sylvia Adams et al. · Journal of Clinical Oncology · 2019 · 828 citations · Full text